Clinical trial
Recurrence Patterns and Cost-Effectiveness of Robotic-assisted, Laparoscopic, and Open Liver Resection in BCLC 0/A Hepatocellular Carcinoma:
NCT06776185 is registered in ClinicalTrials.gov with Chen Xiaoping as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Recurrence Patterns and Cost-Effectiveness of Robotic-assisted, Laparoscopic, and Open Liver Resection in BCLC 0/A Hepatocellular Carcinoma:
- Lead sponsor
- Chen Xiaoping
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 15, 2022
- Completion date
- November 15, 2024
- Enrollment
- 3,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hcc - hepatocellular carcinoma